Clinical Trials Directory

Trials / Completed

CompletedNCT01864044

Prospective Observational Lymphoedema Intensive Treatment

Status
Completed
Phase
Study type
Observational
Enrollment
306 (actual)
Sponsor
Thuasne · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this observational study was to describe usual practices in lymphedema management in France. It was the opportunity to assess the effects of these practices on lymphedema volume in a large number of patients, to identify predictive factors of response, and to assess the safety of this therapy.

Detailed description

Lymphoedema is commonly treated according a strategy called Complex Decongestive Therapy (CDT). This CDT is usually composed of 2 different treatment phases. The first phase is an acute phase which aim is to reduce affected limb volume. The second phase is a maintenance phase which aim is to maintain as long as possible the volume reduction acheived during the first phase. These 2 phases required multi modal parameters such as bandages, lymphatic drainages, physical exercises...and can be managed very differently from one site to another.

Conditions

Timeline

Start date
2009-09-01
Primary completion
2011-03-01
Completion
2012-12-01
First posted
2013-05-29
Last updated
2023-11-22

Source: ClinicalTrials.gov record NCT01864044. Inclusion in this directory is not an endorsement.

Prospective Observational Lymphoedema Intensive Treatment (NCT01864044) · Clinical Trials Directory